FOCUS-Demand for weight-loss drugs fuels global rise in counterfeits

Extraordinary demand for Novo Nordisk’s Ozempic and other drugs used for weight-loss is fueling a global surge in counterfeit versions, according to Reuters interviews with law enforcement, anti-counterfeiting and public health officials. The U.S.-based Pharmaceutical Security Institute (PSI), an industry-backed organization that counts drugmakers Novo Nordisk and Eli Lilly as members, said it is working with agencies, including Europol, Interpol and U.S. Homeland Security, as well as companies that help identify counterfeit products such as Israel’s BrandShield.

Related Keywords

United States ,Ireland ,Russia ,Egypt ,World Health Organization ,Al Qahirah ,United Kingdom ,Germany ,America ,Britain ,Maggie Fick ,Patrick Wingrove ,Novo Ozempic ,Lilly Mounjaro ,Eli Lilly ,Novo Nordisk Ozempic ,Jim Mancuso ,Aurora Ellis ,Yoav Keren ,Novo Nordisk ,Ireland Health Products Regulatory Authority ,Regulatory Agency ,Reuters ,U Pharmaceutical Security Institute ,A World Health Organization ,Drug Administration ,Pharmaceutical Security Institute ,Homeland Security ,Intellectual Property Rights Coordination ,North America ,Middle East ,Health Products Regulatory Authority ,Counterfeit Products ,Weight Loss Drug ,Europol ,Interpol ,Make Drugs ,Law Enforcement ,Weight Loss ,Diabetes ,